## Note
nid: 1497382748606
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::!FLAG_THESE_CARDS::!DELETE, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies::Alemtuzumab, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::20_Alemtuzumab, #AK_Step1_v11::#OME_banner::Basic_Science::07_Immunology, #AK_Step1_v11::#Physeo::09_Pharm::17_Hem/Onc_Pharm::Rituximab_Bevacizumab_Alemtuzumab_Cetuximab_Panitumumab_Trastuzmab, #AK_Step1_v11::#SketchyPharm::Immunology-&-Biochemistry-Pharmacology::Immuno-suppressives::General-Immunotherapy, #AK_Step1_v11::^Other::^EXPN, #AK_Step1_v11::^Other::^HighYield::1-HighYield
markdown: false

### Text
<div>
  <i><b>Alemtuzumab</b></i> is a monoclonal antibody against the
  cell surface marker <b>CD{{c2::52}}</b>, which is expressed by
  {{c1::<b>Lymphocytes</b>}}
</div>

### Extra
<img src="paste-91431263797249.jpg">

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/immunology?ref=anki"><img src=
  "_OME_AnkiFlashcards_Topic_3.png"></a>
</div>

### Additional Resources


### One by one

